Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
ENTX
#3424
Entera Bio Ltd. Ordinary Shares
1.3
9
-8.55%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-8.55%
Variazione Mensile
-11.46%
Variazione di 6 mesi
-30.15%
Variazione Annuale
-27.60%
Chiusura Precedente
1.5
2
Open
1.3
9
Bid
Ask
Low
1.3
9
High
1.3
9
Volume
2
Mercati
Mercato Azionario Statunitense
Salute
ENTX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
36.83 M
45.42 M
45.45 M
45.66 M
45.86 M
—
Valuation ratios
Enterprise value
63.07 M
87.63 M
64.7 M
75.9 M
79.47 M
307.7 M
Price to earnings ratio
7.31
8.48
6.54
7.31
8
30.33
Price to sales ratio
716.31
440.99
293.17
445.81
610.26
1 790.23
Price to cash flow ratio
-8.12
-11.71
-10.33
-11.63
-12.05
-45.72
Price to book ratio
1.9
9.88
1.6
1.58
1.42
14.48
Enterprise value to EBITDA ratio
-6.65
-9.19
-6.44
-7.19
-7.37
-30.19
Profitability ratios
Return on assets %
0.39
0.25
0.12
0.14
0.18
0.69
Return on equity %
0.47
0.29
0.13
0.15
0.21
0.79
Return on invested capital %
2 062.87
1 614.6
—
—
—
—
Gross margin %
0
0
0
—
—
—
Operating margin %
7 109.52
2 832.93
6 102.38
—
—
—
EBITDA margin %
-7 166.67
-2 836.59
-6 083.33
—
—
—
Net margin %
7 192.86
2 875.61
6 111.9
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.61
7.63
13.07
10.47
10.83
42
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.02
0.03
0.03
—
Long term debt to total equity ratio
—
—
0.03
0.03
0.03
—
Per share metrics
Operating cash flow per share
0.06
0.04
0.03
0.04
0.05
0.16
EBIT per share
-0.08
-0.06
-0.06
-0.06
-0.07
-0.25
EBITDA per share
-0.08
-0.06
-0.06
-0.06
-0.07
-0.25
Total debt per share
—
—
—
—
—
—
Cash per share
0.19
0.23
0.29
0.24
0.19
0.95
Net current asset value per share
0.2
0.24
0.49
0.43
0.37
1.53
Tangible book value per share
0.17
0.21
0.45
0.38
0.33
1.38
Working capital per share
0.17
0.21
0.45
0.39
0.34
1.38
Book value per share
0.17
0.21
0.45
0.38
0.33
1.38
Notizie
What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)
Opko Health: rating "Buy" confermato da H.C. Wainwright
Opko Health stock rating reiterated at Buy by H.C. Wainwright
Entera Bio nomina Geno Germano presidente del consiglio di amministrazione
Entera Bio appoints Geno Germano as board chairman
OPKO and Entera expand collaboration to develop oral PTH treatment
Entera Bio pianifica la presentazione alla FDA del farmaco per l’osteoporosi nel Q1 2026
Entera Bio plans FDA submission for osteoporosis drug in Q1 2026
H.C. Wainwright conferma rating Buy su Entera Bio dopo qualifica FDA endpoint BMD
H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint
L’analogo orale di PTH di Entera Bio mostra una risposta sostenuta del calcio
Entera Bio’s oral PTH analog shows sustained calcium response